![](/img/cover-not-exists.png)
PROSTATE-SPECIFIC ANTIGEN RESPONSE TO DEFERRED COMBINED ANDROGEN BLOCKADE THERAPY USING BICALUTAMIDE PREDICTS SURVIVAL AFTER SUBSEQUENT OESTROGEN AND DOCETAXEL THERAPIES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
Marc B. GarnickVolume:
110
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1464-410x.2012.11061.x
File:
PDF, 47 KB
english, 2012